West Pharmaceutical Services Inc (BSP:W2ST34)
R$ 55.16 0.16 (0.29%) Market Cap: 139.83 Bil Enterprise Value: 138.71 Bil PE Ratio: 48.32 PB Ratio: 8.58 GF Score: 91/100

West Pharmaceutical Services Inc at Morgan Stanley Healthcare Conference Transcript

Sep 09, 2019 / 01:20PM GMT
Marissa Elizabeth Bych
Morgan Stanley, Research Division - Research Associate

(technical difficulty)

medical technology with David Lewis. I'm med tech analyst here at Morgan Stanley. And I'm here this morning with West Pharmaceutical Services. We have Eric Green, CEO; and also Bernard Birkett, the CFO with us. And I'm very excited to have you both, especially you coming off of a very strong first half of the year. We'll talk some more about the financials later, but understand you delivered nearly 10% organic growth over the first half. Just rose at second quarter for the full year by about $10 million.

Questions & Answers

Marissa Elizabeth Bych;Eric M
Morgan Stanley, Research Division - Research Associate

Let's start off maybe at a higher level talking about the business for those who may be less familiar. Just tell us a little bit about what is West Pharmaceutical Services. Talk about the higher barriers to entry in your space. Talk about your customer mix through geographic exposure and some of those higher level items.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot